| YHL041W |
Saccharomyces cerevisiae |
|
YHL041W is differentially expressed in 7 experiments [7 up/5 dn]: 3 compound treatments: doxycycline [1 up/0 dn], none [0 up/1 dn], ...; 7 genotypes: tetO2-PAF1-6HA [1 up/0 dn], abf1-1 hypomorph / GAL-ABF1 overexpression transgene [1 up/0 dn], ...; 2 strain or lines |
| YHL041W |
|
|
|
P38730
|
|
|
|
YHL041W
|
|
|
| Factor Value |
Factor |
Up/Down |
Legend: - number of studies the gene is up/down in
|
|
Doxycycline
|
Compound treatment |
|
|
None
|
Compound treatment |
|
|
TetO2-PAF1-6HA
|
Genotype |
|
|
Commercial dry active yeast
|
Strain or line |
|
|
BY4743
|
Strain or line |
|
|
Abf1-1 hypomorph / GAL-ABF1 ov...
|
Genotype |
|
|
Bcs1/bcs1
|
Genotype |
|
|
H3(K4,9,14,18,23,27Q)
|
Genotype |
|
|
GAL-ABF1 overexpression transg...
|
Genotype |
|
|
UASGAL1-IFH1-13myc-TRP1
|
Genotype |
|
|
IFH1-13myc-TRP1
|
Genotype |
|
|
Sodium chloride
|
Compound treatment |
|
|
|
|
|
Processing time: 0.02 secs.